Carbamate glycolipid and use thereof
US9493497B2 · kind B2 · utility
0Cited by
3References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 26, 2013 |
| Grant date | Nov 15, 2016 |
| Priority date | — |
| Expiry date | May 5, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N5/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a compound effective as an antitumor active agent or vaccine adjuvant and an intermediate useful for the synthesis of the compound, as well as production methods thereof, and a medicament containing the novel compound. The compound is a carbamate glycolipid represented by the formula (I)wherein each symbol is as defined herein. The invention also provides a dendritic cell pulsed with the glycolipid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.